Rocket Lab (NASDAQ:RKLB) Stock Price Down 1.2% - Should You Sell?

Key Points

• Neutron rocket delay and a related manufacturing defect are the primary near‑term execution risks weighing on the stock, contributing to recent share weakness (down ~1.2% intraday).
• Large insider sales — including CEO and CFO disposals totaling millions of shares (and tens of millions of dollars) — are creating retail nervousness and may increase short‑term volatility despite being disclosed to the SEC.
• Offsetting catalysts include a successful hypersonic scramjet test and new silicon solar array efforts plus heavy institutional accumulation (notable stakes by Vanguard and Baillie Gifford), supporting a roughly $1.85B backlog and an average analyst view of a "Moderate Buy" (avg target ≈ $75.92).

Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) dropped 1.2% during mid-day trading on Tuesday . The company traded as low as $66.19 and last traded at $70.13. Approximately 17,287,629 shares changed hands during trading, a decline of 21% from the average daily volume of 21,996,840 shares. The stock had previously closed at $70.97.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Successful hypersonic test lift for a scramjet-powered air vehicle for the U.S. Defense Innovation Unit — expands Rocket Lab’s role in defense test services and could increase government contract revenue visibility. Rocket Lab Lifts Scramjet-Powered Air Vehicle For DIU Hypersonic Test
• Positive Sentiment: Rocket Lab highlighted broader hypersonic testing success and launched advanced silicon solar arrays aimed at powering future space-based data centers — diversifying revenue avenues beyond launch services. Rocket Lab Expands Hypersonic Testing And Space Power Ambitions For Investors
• Positive Sentiment: Institutional investors continue to accumulate RKLB despite insider selling; MarketBeat notes a large backlog (~$1.85B) and rising institutional ownership, which supports valuation and offsets optics of insider liquidity. Meta and Rocket Lab Insiders Sell Shares—So Why Is Wall Street Buying?
• Neutral Sentiment: Some analyst movement is mixed: Needham trimmed its price target (from $110 to $95) but kept a buy rating, while other shops have reiterated market-perform or set different targets — a sign of divergent analyst views. Needham Price Target Note (Benzinga)
• Negative Sentiment: Execution risk from the Neutron rocket delay and a manufacturing defect in a tank test continues to weigh on sentiment; the delay has extended the post-earnings pullback and is the primary near-term driver of weakness. What's Going On With Rocket Lab Stock Monday? (Benzinga)
• Negative Sentiment: High-profile insider sales (founder and senior executives) create retail investor nervousness despite institutional absorption; optics can drive short-term volatility. Insider Selling Coverage (MarketBeat)

Wall Street Analyst Weigh In

RKLB has been the subject of a number of recent analyst reports. Morgan Stanley upgraded shares of Rocket Lab from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $67.00 to $105.00 in a research report on Friday, January 16th. KeyCorp lowered shares of Rocket Lab from an "overweight" rating to a "sector weight" rating in a report on Thursday, January 15th. TD Cowen reissued a "buy" rating on shares of Rocket Lab in a report on Thursday, January 22nd. Needham & Company LLC decreased their price target on Rocket Lab from $110.00 to $95.00 and set a "buy" rating on the stock in a research report on Friday. Finally, Wall Street Zen upgraded Rocket Lab from a "sell" rating to a "hold" rating in a research report on Sunday, February 8th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $75.92.

Rocket Lab Stock Performance

The stock has a market cap of $37.44 billion, a price-to-earnings ratio of -189.43 and a beta of 2.20. The company has a current ratio of 3.18, a quick ratio of 2.83 and a debt-to-equity ratio of 0.32. The firm has a fifty day simple moving average of $77.98 and a 200-day simple moving average of $61.45.

Insider Buying and Selling at Rocket Lab

In other Rocket Lab news, CFO Adam C. Spice sold 1,365,665 shares of the business's stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $75.50, for a total transaction of $103,107,707.50. Following the completion of the sale, the chief financial officer directly owned 1,359,568 shares of the company's stock, valued at approximately $102,647,384. The trade was a 50.11% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Peter Beck sold 1,560,254 shares of the firm's stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $57.47, for a total transaction of $89,667,797.38. Following the completion of the transaction, the chief executive officer directly owned 939,746 shares in the company, valued at $54,007,202.62. This trade represents a 62.41% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 4,138,979 shares of company stock valued at $265,048,346 over the last ninety days. Company insiders own 11.90% of the company's stock.

Hedge Funds Weigh In On Rocket Lab

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its stake in shares of Rocket Lab by 13.4% in the 4th quarter. Vanguard Group Inc. now owns 47,420,192 shares of the rocket manufacturer's stock valued at $3,308,033,000 after purchasing an additional 5,610,469 shares during the period. Baillie Gifford & Co. grew its stake in shares of Rocket Lab by 47.2% during the fourth quarter. Baillie Gifford & Co. now owns 17,851,446 shares of the rocket manufacturer's stock worth $1,245,317,000 after purchasing an additional 5,725,536 shares during the period. Capital World Investors increased its holdings in Rocket Lab by 12.0% in the fourth quarter. Capital World Investors now owns 16,200,726 shares of the rocket manufacturer's stock valued at $1,130,172,000 after purchasing an additional 1,738,623 shares during the last quarter. State Street Corp lifted its stake in Rocket Lab by 1.0% in the fourth quarter. State Street Corp now owns 12,520,223 shares of the rocket manufacturer's stock valued at $873,411,000 after buying an additional 120,652 shares during the period. Finally, Geode Capital Management LLC lifted its stake in Rocket Lab by 10.1% in the fourth quarter. Geode Capital Management LLC now owns 9,004,724 shares of the rocket manufacturer's stock valued at $626,605,000 after buying an additional 825,158 shares during the period. 71.78% of the stock is owned by institutional investors.

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.